Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Beta-blocker Reduction on Exercise in AF
NCT05332457Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol in Atrial fibrillation (AFib) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Peak oxygen intake at Day 21 and Chronotropic response to exercise at Day 21. Started Jul 2025; status: recruiting.
02
Drugs
carvedilol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05332457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05332457.